Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
Smoots, Stephen G, Schreiber, Anna R, Jackson, Marilyn M, Bagby, Stacey M, Dominguez, Adrian T A, Dus, Evan D, Binns, Cameron A, MacBeth, Morgan, Whitty, Phaedra A, Diamond, Jennifer R, Pitts, Todd M
Published in Breast cancer research : BCR (01.03.2024)
Published in Breast cancer research : BCR (01.03.2024)
Get full text
Journal Article
Abstract LB_C06: Utilizing a novel HDAC inhibitor bocodepsin (OKI-179) to overcome doxorubicin resistance in triple-negative breast cancer
Smoots, Stephen G, Schreiber, Anna R, Jackson, Marilyn M, Dus, Evan D, Bagby, Stacey M, Dominguez, Adrian T A., Binns, Cameron A, Diamond, Jennifer R, Pitts, Todd M
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract LB_C07: Utilizing a BCL-2 inhibitor (venetoclax) to overcome doxorubicin resistance in triple-negative breast cancer
Dus, Evan D, Smoots, Stephen G, Schreiber, Anna R, Jackson, Marilyn M, Bagby, Stacey M, Dominguez, Adrian T A, Binns, Cameron A, Pitts, Todd M, Diamond, Jennifer R
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article